<DOC>
	<DOCNO>NCT02555358</DOCNO>
	<brief_summary>The purpose study ass relationship pCR rate efficacy compare two drug three drug neoadjuvant chemotherapy advance gastric cancer patient .</brief_summary>
	<brief_title>Three Drugs Advanced Gastric Cancer Neoadjuvant Chemotherapy Stage Ⅲ Clinical Study</brief_title>
	<detailed_description>Eligible patient randomly assign randomisation system 1:1:1 ratio three group . The group A wil receive four cycle DOX ( docetaxel 60mg/m2 day 1 , oxaliplatin 130mg/m2 day 1 capecitabine 1,000 mg/m2 per day day 1 14 , repeat every 3 week ) neoadjuvant therapy four cycle Xelox ( capecitabine 1,000 mg/m2 per day day 1 14 oxaliplatin 130mg/m2 day 1 , repeat every 3 week ) adjuvant therapy.The group B wil receive four cycle Xelox ( capecitabine 1,000 mg/m2 per day day 1 14 oxaliplatin 130mg/m2 day 1 , repeat every 3 week ) neoadjuvant therapy four cycle Xelox adjuvant therapy.The group C wil receive eight cycle Xelox ( capecitabine 1,000 mg/m2 per day day 1 14 oxaliplatin 130mg/m2 day 1 , repeat every 3 week ) adjuvant therapy .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>1 . Histologically cytologically proven operable advanced gastric adenocarcinoma ; 2 . Subjects identify potentially resectable case multidisciplinary consultation ; 3 . KPS &gt; 80 ; ECOG score : 01 ; 4 . Expected survival &gt; 6 month ; 5 . Age 20 60 ; 6 . Major organ function meet follow criterion : Neutrophil count ≥1.5 × 109 / L , platelet count ≥100 × 109 / L , Hemoglobin ≥90g / L , liver function &lt; 1.5 time upper limit normal , serum bilirubin ≤1.0 × UNL , serum creatinine &lt; 1.5 × UNL , PTINR / PTT &lt; 1.7 time upper limit normal ; 7 . Subjects voluntarily join study sign Informed Consent Form study ; 1 . Associated serious disease liver , kidney , cardiovascular system vital organ ; 2 . History hypersensitivity docetaxel , capecitabine , oxaliplatin ingredient product ; 3 . Receiving form chemotherapy study medication ; 4 . Pregnancy lactation woman , woman suspect pregnancy men unless use reliable appropriate contraceptive method ; 5 . Associated inability swallow , haemorrhagic peptic ulcer , mechanical paralytic ileus , gastrointestinal active bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Resectable advanced gastric cancer</keyword>
</DOC>